Skip to Main content Skip to Navigation
New interface
Journal articles

Alkoxyamines: a new family of pro-drugs against cancer. Concept for theranostics

Abstract : Development of anti-cancerous theranostic agents is a vivid field. This article describes a theranostic approach that relies on the triggering of cancer cell death by generation of alkyl radicals at the right place and at the right time using the presence of active proteases in the tumour environment. Alkoxyamines ((RRNOR3)-R-1-N-2) are labile molecules that homolyze into nitroxides ((RRNO center dot)-R-1-N-2) and reactive alkyl radicals (R-3 center dot). They are used as a source of active alkyl radicals for curing and nitroxides for monitoring by Overhauser-enhanced magnetic resonance imaging (OMRI). Herein, the requirements needed for applying alkoxyamines are described: (i) highly selective activation of the alkoxyamine by specific proteases; (ii) fast homolysis of the alkoxyamine C-ON bond at physiological temperature; (iii) activation of cell death processes through an increase of the local oxidative stress or potential re-activation of the immune system due to short-lived alkyl radicals; and (iv) imaging of the tumor and the drug release by sensing the nitroxide by OMRI.
Document type :
Journal articles
Complete list of metadata
Contributor : Didier Gigmes Connect in order to contact the contributor
Submitted on : Tuesday, February 7, 2017 - 4:54:13 PM
Last modification on : Tuesday, September 27, 2022 - 4:17:31 AM




Gérard Audran, Paul Brémond, Jean-Michel Franconi, Sylvain R.A. Marque, Philippe Massot, et al.. Alkoxyamines: a new family of pro-drugs against cancer. Concept for theranostics. Organic & Biomolecular Chemistry, 2014, 12 (5), pp.719--723. ⟨10.1039/c3ob42076k⟩. ⟨hal-01460497⟩



Record views